A Silicon dioxide, chemically prepared CEP of the European Pharmacopoeia monograph is often referred to as a Silicon dioxide, chemically prepared Certificate of Suitability (COS). The purpose of a Silicon dioxide, chemically prepared CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Silicon dioxide, chemically prepared EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Silicon dioxide, chemically prepared to their clients by showing that a Silicon dioxide, chemically prepared CEP has been issued for it. The manufacturer submits a Silicon dioxide, chemically prepared CEP (COS) as part of the market authorization procedure, and it takes on the role of a Silicon dioxide, chemically prepared CEP holder for the record. Additionally, the data presented in the Silicon dioxide, chemically prepared CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Silicon dioxide, chemically prepared DMF.
A Silicon dioxide, chemically prepared CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Silicon dioxide, chemically prepared CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Silicon dioxide, chemically prepared suppliers with CEP (COS) on PharmaCompass.